Clinomics Inc
KOSDAQ:352770
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Shareholder Yield
Current shareholder yield for Clinomics Inc is .
Dividends, buybacks and debt paydown, as one yield.
Create a free account · No card needed
Create a free account · No card needed
Create a free account · No card needed
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Clinomics Inc
| Average Annual Return | 187.97% |
| Standard Deviation of Annual Returns | 481.55% |
| Max Drawdown | -96% |
| Market Capitalization | 13.4B KRW |
| Shares Outstanding | 2 590 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Clinomics Inc's latest stock split occurred on Aug 10, 2023
The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.
Before the split, Clinomics Inc traded at 4845.0001 per share. Afterward, the share price was about 3320.
The adjusted shares began trading on Aug 10, 2023. This was stock split number 2 in Clinomics Inc's history, following the previous one in Jun 27, 2023.